1. Home
  2. CATY vs SLNO Comparison

CATY vs SLNO Comparison

Compare CATY & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATY
  • SLNO
  • Stock Information
  • Founded
  • CATY 1962
  • SLNO 1999
  • Country
  • CATY United States
  • SLNO United States
  • Employees
  • CATY N/A
  • SLNO N/A
  • Industry
  • CATY Major Banks
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CATY Finance
  • SLNO Health Care
  • Exchange
  • CATY Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • CATY 2.7B
  • SLNO 3.2B
  • IPO Year
  • CATY N/A
  • SLNO 2014
  • Fundamental
  • Price
  • CATY $42.94
  • SLNO $76.78
  • Analyst Decision
  • CATY Hold
  • SLNO Strong Buy
  • Analyst Count
  • CATY 5
  • SLNO 9
  • Target Price
  • CATY $49.60
  • SLNO $103.33
  • AVG Volume (30 Days)
  • CATY 418.6K
  • SLNO 955.8K
  • Earning Date
  • CATY 04-21-2025
  • SLNO 05-07-2025
  • Dividend Yield
  • CATY 3.16%
  • SLNO N/A
  • EPS Growth
  • CATY N/A
  • SLNO N/A
  • EPS
  • CATY 3.95
  • SLNO N/A
  • Revenue
  • CATY $691,279,000.00
  • SLNO N/A
  • Revenue This Year
  • CATY $16.75
  • SLNO N/A
  • Revenue Next Year
  • CATY $7.13
  • SLNO N/A
  • P/E Ratio
  • CATY $10.90
  • SLNO N/A
  • Revenue Growth
  • CATY N/A
  • SLNO N/A
  • 52 Week Low
  • CATY $34.46
  • SLNO $36.93
  • 52 Week High
  • CATY $55.29
  • SLNO $80.91
  • Technical
  • Relative Strength Index (RSI)
  • CATY 56.48
  • SLNO 65.28
  • Support Level
  • CATY $40.96
  • SLNO $72.23
  • Resistance Level
  • CATY $43.67
  • SLNO $80.99
  • Average True Range (ATR)
  • CATY 1.40
  • SLNO 3.06
  • MACD
  • CATY 0.31
  • SLNO -0.37
  • Stochastic Oscillator
  • CATY 83.10
  • SLNO 64.59

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: